Application Information

This drug has been submitted to the FDA under the reference 021854/001.

Names and composition

"STAVUDINE; LAMIVUDINE W/NEVIRAPINE" is the commercial name of a drug composed of STAVUDINE and LAMIVUDINE and NEVIRAPINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021854/001 STAVUDINE; LAMIVUDINE W/NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 40MG and 150MG and 200MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021837/001 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 40MG and 150MG and 200MG
021854/001 STAVUDINE; LAMIVUDINE W/NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 40MG and 150MG and 200MG
022177/001 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 30MG and 150MG and 200MG
022342/001 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 30MG and 150MG and 200MG
022342/002 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 40MG and 150MG and 200MG
022346/001 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 30MG and 150MG and 200MG
022346/002 STAVUDINE; LAMIVUDINE; NEVIRAPINE STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET/ ORAL 40MG and 150MG and 200MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved